RedHill Biopharma Ltd. (RDHL)
Total Valuation
RDHL has a market cap or net worth of $15.42 million. The enterprise value is $1.55 million.
Market Cap | 15.42M |
Enterprise Value | 1.55M |
Important Dates
The next estimated earnings date is Friday, April 26, 2024, before market open.
Earnings Date | Apr 26, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
RDHL has 18.18 million shares outstanding.
Shares Outstanding | 18.18M |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 6.70% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 1,428.57 |
PS Ratio | 0.43 |
Forward PS | n/a |
PB Ratio | 4.44 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 0.13 |
EV / Sales | 0.04 |
EV / EBITDA | 0.12 |
EV / EBIT | 0.20 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.66.
Current Ratio | 0.96 |
Quick Ratio | 0.68 |
Debt / Equity | 0.66 |
Debt / EBITDA | 0.17 |
Debt / FCF | n/a |
Interest Coverage | -1.93 |
Financial Efficiency
Return on equity (ROE) is -52.00% and return on invested capital (ROIC) is 132.34%.
Return on Equity (ROE) | -52.00% |
Return on Assets (ROA) | 11.30% |
Return on Capital (ROIC) | 132.34% |
Revenue Per Employee | $316,327 |
Profits Per Employee | $102,407 |
Employee Count | 113 |
Asset Turnover | 0.35 |
Inventory Turnover | 2.46 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.40% in the last 52 weeks. The beta is 3.46, so RDHL's price volatility has been higher than the market average.
Beta (1Y) | 3.46 |
52-Week Price Change | -89.40% |
50-Day Moving Average | 0.60 |
200-Day Moving Average | 0.92 |
Relative Strength Index (RSI) | 43.44 |
Average Volume (30 Days) | 1,335,862 |
Short Selling Information
Short Interest | 1.06M |
Short Previous Month | 376,153 |
Short % of Shares Out | 1.27% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.53 |
Income Statement
In the last 12 months, RDHL had revenue of $35.75 million and earned $11.57 million in profits.
Revenue | 35.75M |
Gross Profit | 15.28M |
Operating Income | 7.62M |
Pretax Income | 11.57M |
Net Income | 11.57M |
EBITDA | 13.30M |
EBIT | 7.62M |
Earnings Per Share (EPS) | -$8.00 |
Balance Sheet
The company has $16.15 million in cash and $2.28 million in debt, giving a net cash position of $13.87 million or $0.76 per share.
Cash & Cash Equivalents | 16.15M |
Total Debt | 2.28M |
Net Cash | 13.87M |
Net Cash Per Share | $0.76 |
Equity / Book Value | 3.47M |
Book Value Per Share | 0.19 |
Working Capital | -1.14M |
Cash Flow
In the last 12 months, operating cash flow was -$26.22 million and capital expenditures -$29,000, giving a free cash flow of -$26.25 million.
Operating Cash Flow | -26.22M |
Capital Expenditures | -29,000 |
Free Cash Flow | -26.25M |
FCF Per Share | -$8.90 |
Margins
Gross margin is 42.74%, with operating and profit margins of 21.31% and 32.37%.
Gross Margin | 42.74% |
Operating Margin | 21.31% |
Pretax Margin | 32.37% |
Profit Margin | 32.37% |
EBITDA Margin | 37.21% |
EBIT Margin | 21.31% |
FCF Margin | -73.45% |
Dividends & Yields
RDHL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -107.68% |
Shareholder Yield | -107.68% |
Earnings Yield | 75.07% |
FCF Yield | -170.30% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 23, 2023. It was a reverse split with a ratio of 1:40.
Last Split Date | Mar 23, 2023 |
Split Type | Reverse |
Split Ratio | 1:40 |
Scores
RDHL has an Altman Z-Score of -13.27 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -13.27 |
Piotroski F-Score | 5 |